In 2025, Pfizer spent some billion U.S. dollars on R&D efforts. Pfizer is a multinational pharmaceutical company that is headquartered in New York City, New York. Pfizer’s expenditures on research and development (R&D) have been variable in recent history.
Pfizer’s company profile
Pfizer is one of the world’s largest pharmaceutical companies. The company has pharmaceuticals in many therapeutic areas, including oncology, endocrinology, cardiology, and neurology. The Prevnar family is one of Pfizer’s major revenue-generating drugs. Prevnar is a vaccine used to prevent pneumococcal pneumonia. The company has undergone several mergers and acquisitions in recent history. In 1999, Pfizer and Warner-Lambert joined, forming one of the most valuable pharmaceutical mergers of all time.
Pharmaceutical research and development
Pharmaceutical R&D is crucial for finding and creating new drug compounds and agents that have the potential to save lives (or improve medical symptoms). Pharmaceutical R&D in the U.S. has become a booming industry, and spending is increasing year-over-year. The number of federally registered clinical trials in the U.S. has been increasing significantly recently as well. One area of health that has been significantly impacted by R&D investment is oncology.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
Pfizer, & U.S. Securities and Exchange Commission. (February 26, 2026). Research and development expenditure of Pfizer from 2006 to 2025 (in million U.S. dollars) [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 14, 2026, from /statistics/267810/expenditure-on-research-and-development-at-pfizer-since-2006/
Pfizer, und U.S. Securities and Exchange Commission. "Research and development expenditure of Pfizer from 2006 to 2025 (in million U.S. dollars)." Chart. February 26, 2026. ÌÇÐÄÆƽâ°æ. Accessed July 14, 2026. /statistics/267810/expenditure-on-research-and-development-at-pfizer-since-2006/
Pfizer, U.S. Securities and Exchange Commission. (2026). Research and development expenditure of Pfizer from 2006 to 2025 (in million U.S. dollars). ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 14, 2026. /statistics/267810/expenditure-on-research-and-development-at-pfizer-since-2006/
Pfizer, and U.S. Securities and Exchange Commission. "Research and Development Expenditure of Pfizer from 2006 to 2025 (in Million U.S. Dollars)." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 26 Feb 2026, /statistics/267810/expenditure-on-research-and-development-at-pfizer-since-2006/
Pfizer & U.S. Securities and Exchange Commission, Research and development expenditure of Pfizer from 2006 to 2025 (in million U.S. dollars) ÌÇÐÄÆƽâ°æ, /statistics/267810/expenditure-on-research-and-development-at-pfizer-since-2006/ (last visited July 14, 2026)
Research and development expenditure of Pfizer from 2006 to 2025 (in million U.S. dollars) [Graph], Pfizer, & U.S. Securities and Exchange Commission, February 26, 2026. [Online]. Available: /statistics/267810/expenditure-on-research-and-development-at-pfizer-since-2006/
